All lobbying filings

RK STRATEGIES, INC.

Lobbying for CLEARMIND MEDICINE, INC · Developer of Psychedelics Medicines

Filing 4th Quarter - Report

4th Quarter (Oct 1 - Dec 31) 2025 · British Columbia · House · Senate · $10,000.00 income · posted Jan 20, 2026

Official filing document

Bills named in this filing 3

HR 7091
Expanding Veterans’ Access to Emerging Treatments Act
HR 2623
Innovative Therapies Centers of Excellence Act of 2025
HR 3838
Streamlining Procurement for Effective Execution and Delivery and National Defense Authorization Act for Fiscal Year 20…

Lobbying activity 4

Defense

Psychedelic Legislation H.R. 7091, Expanding Veterans Access to Emerging Treatments Act H.R.2623, Innovative Therapies Centers of Excellence Act of 2025

Alcohol and Drug Abuse

H.R. 3838, the Streamlining Procurement for Effective Execution and Delivery (SPEED) Act H.R. 7091, Expanding Veterans Access to Emerging Treatments Act H.R.2623, Innovative Therapies Centers of Excellence Act of 2025

Veterans

H.R. 7091, Expanding Veterans Access to Emerging Treatments Act H.R.2623, Innovative Therapies Centers of Excellence Act of 2025 Psychedelics issues

Health Issues

H.R. 7091, Expanding Veterans Access to Emerging Treatments Act H.R.2623, Innovative Therapies Centers of Excellence Act of 2025

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.